July 28 (Reuters) - Trevena Inc TRVN.O :
* TREVENA ANNOUNCES POSITIVE TOPLINE OLINVYK COGNITIVE
FUNCTION
DATA AND PROVIDES GENERAL BUSINESS UPDATE
* TREVENA INC - OLINVYK DEMONSTRATED STATISTICALLY
SIGNIFICANT
REDUCED IMPACT ON NEUROCOGNITIVE FUNCTIONING VERSUS IV MORPHINE
ON PRIMARY ENDPOINT
* TREVENA INC - NOVEL S1P RECEPTOR MODULATOR TRV045 FOR
DIABETIC
NEUROPATHIC PAIN ON TRACK FOR COMPLETION OF PHASE 1 IN 2H 2022
* TREVENA INC - STRATEGIC ALLOCATION OF RESOURCES AND COST
REDUCTIONS REINFORCE KEY FOCUS AREAS AND EXTENDS CASH RUNWAY TO
MID-2023
Source text for Eikon: ID:nGNX4ly6nv
Further company coverage: TRVN.O
((Reuters.Briefs@thomsonreuters.com;))